deCODE genetics: Variants in the genome affect DNA methylation
REYKJAVIK, Iceland, July 24, 2024 /PRNewswire/ -- A new study by scientists at deCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linked to various diseases as well as other human traits. deCODE genetics: Variants in the genome affect DNA methylation ...
The Infinitus Global R&D Center Achieves CNAS Accreditation
GUANGZHOU, China, Aug. 19, 2024 /PRNewswire/ -- The Infinitus Global R&D Center has successfully passed an on-site evaluation by the expert panel from the China National Accreditation Service for Conformity Assessment (CNAS), marking the third consecutive recognition for Infinitus following the accreditations of the Xinhui and Yingkou Testing Centers. The Infinitus Global R&D Center...
Personalised Energy Expenditure Data Enhances Weight Loss in Obesity: New Study Findings
PERTH, Australia, Sept. 26, 2024 /PRNewswire/ -- A groundbreaking study published in Clinical Obesity reveals that providing personalised energy expenditure data significantly improves weight loss outcomes in individuals with obesity1. Conducted by researchers at Liverpool University Hospitals NHS Foundation Trust, this new randomised controlled study demonstrates the efficacy of using indirect calorimetry (ECAL™, Metabolic Health Solutions, Perth, Western Australia) to...
TiumBio Announces First Patient Dosed in Phase 2 Clinical Trial of Oral Immuno-Oncology Drug TU2218
TU2218 is a potentially first-in-class dual inhibitor targeting transforming growth factor beta receptor 1 (TGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2) The first patient with head and neck squamous cell carcinoma was dosed in the Phase 2a clinical trial of TU2218 The Phase 2a trial of TU2218 starts...
KeyBioscience Announces Extension of Strategic Collaboration with Lilly
Companies to extend collaboration on DACRAs with an additional collaboration molecule and investigation of the DACRA platform within multiple indications LUGANO, Switzerland, Oct. 10, 2024 /PRNewswire/ -- KeyBioscience and Eli Lilly and Company have agreed to extend their collaboration on the development of Dual Amylin Calcitonin Receptor Agonists (DACRA), a new class of...
Singapore’s IMAGINE AI: Largest Global Gathering to Shape the Future of Healthcare with AI Innovations
SINGAPORE, Dec. 6, 2024 /PRNewswire/ -- IMAGINE AI is the largest calendar event in Singapore that brings together the brightest minds in healthcare and artificial intelligence to explore the transformative potential of AI in healthcare. Hosted at the Marina Bay Sands Expo & Convention Centre, this biennial event features a diverse...
Transcenta Presented Two Scientific Posters at SITC 2022 Annual Meeting
SUZHOU, China, Nov. 11, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it has presented two scientific posters at the 37th Society for Immunotherapy of Cancer's (SITC) Annual Meeting in Boston, MA, November 8-12, 2022. One related to...
AcuCort signs its first commercial agreement for the company’s drug Zeqmelit™
LUND, Sweden, Nov. 24, 2022 /PRNewswire/ -- AcuCort AB (publ) (Spotlight Stock Market: ACUC) today announces that the company has signed an exclusive commercial agreement with the global biopharmaceutical company Kamada Ltd., (NASDAQ: KMDA; TASE: KMDA.TA). The agreement gives Kamada the exclusive right to the marketing and sales as well as the distribution of AcuCort's drug Zeqmelit™ for, among other...
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board
SINGAPORE and SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey Lodish as the Chair of the Scientific Advisory Board. He joins Prof. Jianzhu Chen of the Massachusetts Institute of Technology (MIT) and Dr. Hagop Youssoufian of Brown University on Carcell's Scientific...
New STIC trial data shows longer overall survival for therapy selection based on CELLSEARCH® CTC count in patients with metastatic breast cancer
Integration of CTC (Circulating Tumor Cell) enumeration* to decide between endocrine therapy and chemotherapy may lead to improved clinical outcomes and quality of life for patients with oestrogen receptor (ER) positive)/human epidermal growth factor receptor (HER) 2 negative metastatic breast cancer (MBC). BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 22, 2022 /PRNewswire/ -- Menarini Silicon Biosystems, a pioneer of...
